PhD Course in Exercise as Medicine
From October 27 to October 30, 2014, Centre for Physical Activity (CFAS) at Rigshospitalet invites PhD students with a background as MD, MSc or equivalent to a PhD course on the topic of exercise as medicine. The course will consist of two parts: the PhD course sessions (October 27-29, 2014) and a symposium on October 30, 2014.
Denmark among Europe's three leading countries in diabetes treatment
Denmark’s diabetes treatment is ranked to be among the three best in Europe. Danish diabetics are among those receiving the best treatment in Europe – only Swedes and Dutchmen are in better hands. This conclusion comes from the Euro Diabetes Index 2014, published Wednesday morning in Vienna.
Working with diabetes?
Join our website - share knowledge and communicate with researchers globallyJoin now
Browse our website to get the latest news regarding Danish Diabetes Academy related events and diabetes researchRead more
World-class educational programmes
We allocate the best grants for educational programmes within the field of diabetes
Danish Diabetes Academy
Represented by world leading experienced scientists, responsible for the overall research strategy of the Academy
Danish Diabetes Academy is building up a platform of networking and knowledge sharing including workshops and seminars at the highest level in the world
Summer School for PhD students
The PhD Network of Diabetes and Metabolism formerly known as the Danish PhD School of Molecular Metabolism is well-known for its annual Summer School at Gl. Avernæs
Highly topical seminars
Annually we host 4 seminars on highly topical issues within diabetes research
Browse our event calendar and get informed about dates of upcoming Danish Diabetes Academy related events and funding callsRead more
Working with Diabetes?
Sign up for the website and become a memberMore...
Fundraising course 28-08-14
Registration deadline: 11 August 2014 (3:00 PM)More...
JDRFs Request for Applications (RFAs)
Funding opportunities in FY 2015 (July 1, 2014 – June 30, 2015)More...
EASD Meeting & Networking 15-08-14
Registration deadline: 8 September 2014 (3:00 PM)More...
Targeting the intestinal L-cell for obesity and type 2 diabetes treatment
Degradation-resistant glucagon-like peptide-1 (GLP-1), mimetics and GLP-1 enhancers have been used for treatment of type 2 diabetes mellitus since 200...Written by: Nicolai J. W. Albrechtsen Read full review